Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Kunwar Shailubhai
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL’s Bridge Program celebrates 40 years of preparing students of every background for college success
Since 2003, 100% of Bridge Program graduates have gone on to college or other postsecondary educational opportunities.
MORE IN Kunwar Shailubhai
LATEST NEWS
- UMSL’s Bridge Program celebrates 40 years of preparing students of every background for college success
- May Optometry graduates help serve hundreds of patients during humanitarian trip to El Salvador
- Midwest Digital Marketing Conference connects professionals, prepares students for an AI-driven future
- Founders showcase the development of their businesses during Anchor Accelerator Demo Day
- UMSL recognizes the exceptional work of its researchers during annual Research and Innovation Celebration
- Doctoral student Anna Heinzmann researching how instituting plea bargaining is altering the legal system in her native Brazil
- Eye on UMSL: The perfect pick-me-up
- UMSL Tritons weekly rewind
- Social work student marshal Erica Martin-Gaines dedicated to making a difference with St. Louis youth
- Vice Chancellor Reggie Hill discusses enrollment and career advancement strategies in latest episode of Inside UMSL podcast
